Throat and Other HPV-Related Cancers in Men: Identifying Them Early
This trial studies the screening of human papillomavirus (HPV)-related oropharyngeal and anogenital cancers. Learning the relationship between HPV and cancer risk in men who test positive for HPV antibodies or circulating HPV DNA may help doctors to develop early methods of screening for certain types of cancer, and screening for HPV may help doctors to learn which patients may be at a higher risk for developing certain types of cancer.
Conditions:
🦠 Human Papillomavirus Infection
🗓️ Study Start (Actual) 28 March 2017
🗓️ Primary Completion (Estimated) 28 March 2027
✅ Study Completion (Estimated) 28 March 2027
👥 Enrollment (Estimated) 1500
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Houston, Texas, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

      Inclusion Criteria:

        Inclusion Criteria:

          Inclusion Criteria:

            Inclusion Criteria:

            • * Eligible for and enrolled in Stage 1
            • * Test positive to HPV16 E antibodies; be identified as a negative control; test positive for oral HPV16 infection by oral rinse; or test positive for cvDNA
            • * Sign an approved informed consent document

            Exclusion Criteria:

    Ages Eligible for Study: 50 Years to 64 Years (ADULT)
    Sexes Eligible for Study: MALE
    Accepts Healthy Volunteers: Yes

    🗓️ Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates

    • First Submitted 7 September 2016
    • First Submitted that Met QC Criteria 7 September 2016
    • First Posted 13 September 2016

    Study Record Updates

    • Last Update Submitted that Met QC Criteria 12 October 2023
    • Last Update Posted 16 October 2023
    • Last Verified October 2023